<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 /home/lopez/grobid/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Runx3 and T-box proteins cooperate to establish the transcriptional program of effector CTLs</title>
			</titleStmt>
			<publicationStmt>
				<publisher>Rockefeller University Press</publisher>
				<availability status="unknown"><p>Copyright Rockefeller University Press</p>
				</availability>
				<date type="published" when="2009-01-12">2009-01-12</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Fernando</forename><surname>Cruz-Guilloty</surname></persName>
							<affiliation key="aff0">
								<orgName type="institution" key="instit1">Harvard Medical School</orgName>
								<orgName type="institution" key="instit2">Immune Disease Institute</orgName>
								<address>
									<postCode>02115</postCode>
									<settlement>Boston</settlement>
									<region>MA</region>
								</address>
							</affiliation>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Matthew</forename><forename type="middle">E</forename><surname>Pipkin</surname></persName>
							<affiliation key="aff0">
								<orgName type="institution" key="instit1">Harvard Medical School</orgName>
								<orgName type="institution" key="instit2">Immune Disease Institute</orgName>
								<address>
									<postCode>02115</postCode>
									<settlement>Boston</settlement>
									<region>MA</region>
								</address>
							</affiliation>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ivana</forename><forename type="middle">M</forename><surname>Djuretic</surname></persName>
							<affiliation key="aff0">
								<orgName type="institution" key="instit1">Harvard Medical School</orgName>
								<orgName type="institution" key="instit2">Immune Disease Institute</orgName>
								<address>
									<postCode>02115</postCode>
									<settlement>Boston</settlement>
									<region>MA</region>
								</address>
							</affiliation>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ditsa</forename><surname>Levanon</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">Department of Molecular Genetics</orgName>
								<orgName type="institution">The Weizmann Institute of Science</orgName>
								<address>
									<postCode>76100</postCode>
									<settlement>Rehovot</settlement>
									<country key="IL">Israel</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Joseph</forename><surname>Lotem</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">Department of Molecular Genetics</orgName>
								<orgName type="institution">The Weizmann Institute of Science</orgName>
								<address>
									<postCode>76100</postCode>
									<settlement>Rehovot</settlement>
									<country key="IL">Israel</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Mathias</forename><forename type="middle">G</forename><surname>Lichtenheld</surname></persName>
							<affiliation key="aff2">
								<orgName type="department" key="dep1">Department of Microbiology and Immunology</orgName>
								<orgName type="department" key="dep2">Sylvester Comprehensive Cancer Center</orgName>
								<orgName type="department" key="dep3">Miller School of Medicine</orgName>
								<orgName type="institution">University of Miami</orgName>
								<address>
									<postCode>10016</postCode>
									<settlement>Miami</settlement>
									<region>FL</region>
								</address>
							</affiliation>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yoram</forename><surname>Groner</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">Department of Molecular Genetics</orgName>
								<orgName type="institution">The Weizmann Institute of Science</orgName>
								<address>
									<postCode>76100</postCode>
									<settlement>Rehovot</settlement>
									<country key="IL">Israel</country>
								</address>
							</affiliation>
						</author>
						<author role="corresp">
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Anjana</forename><surname>Rao</surname></persName>
							<email>arao@idi.harvard.edu</email>
							<affiliation key="aff0">
								<orgName type="institution" key="instit1">Harvard Medical School</orgName>
								<orgName type="institution" key="instit2">Immune Disease Institute</orgName>
								<address>
									<postCode>02115</postCode>
									<settlement>Boston</settlement>
									<region>MA</region>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Runx3 and T-box proteins cooperate to establish the transcriptional program of effector CTLs</title>
					</analytic>
					<monogr>
						<title level="j" type="main">The Journal of Experimental Medicine</title>
						<title level="j" type="abbrev">J Exp Med</title>
						<idno type="ISSN">0022-1007</idno>
						<idno type="eISSN">1540-9538</idno>
						<imprint>
							<publisher>Rockefeller University Press</publisher>
							<biblScope unit="volume">206</biblScope>
							<biblScope unit="issue">1</biblScope>
							<biblScope unit="page" from="51" to="59"/>
							<date type="published" when="2009-01-12" />
						</imprint>
					</monogr>
					<idno type="DOI">10.1084/jem.20081242</idno>
					<idno type="PMID">19139168</idno>
					<idno type="PMCID">PMC2626671</idno>
					<ptr type="open-access" target="http://jem.rupress.org/content/206/1/51.full.pdf" />
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.6.2-SNAPSHOT" ident="GROBID" when="2020-08-14T00:03+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<abstract>
				<p>Activation of naive CD8 + T cells with antigen induces their differentiation into effector cytolytic T lymphocytes (CTLs). CTLs lyse infected or aberrant target cells by exocytosis of lytic granules containing the pore-forming protein perforin and a family of proteases termed granzymes. We show that effector CTL differentiation occurs in two sequential phases in vitro, characterized by early induction of T-bet and late induction of Eomesodermin (Eomes), T-box transcription factors that regulate the early and late phases of interferon (IFN) ␥ expression, respectively. In addition, we demonstrate a critical role for the transcription factor Runx3 in CTL differentiation. Runx3 regulates Eomes expression as well as expression of three cardinal markers of the effector CTL program: IFN-␥ , perforin, and granzyme B. Our data point to the existence of an elaborate transcriptional network in which Runx3 initially induces and then cooperates with T-box transcription factors to regulate gene transcription in differentiating CTLs.</p>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>BRIEF DEFINITIVE REPORT</head><p>Naive CD8 + T cells diff erentiate into eff ector CTLs with the ability to lyse antigen-bearing target cells by exocytosis of lytic granules containing perforin and granzymes, and to produce infl ammatory cytokines such as IFN-␥ and TNF upon restimulation through the TCR <ref type="bibr" target="#b0">( 1,</ref><ref type="bibr" target="#b1">2 )</ref>. In vivo experiments have elucidated many critical parameters governing the development and evolution of primary CTL responses <ref type="bibr" target="#b2">( 3,</ref><ref type="bibr" target="#b3">4 )</ref>. In this study, we have used in vitro systems such as those developed to study CD4 + T cell diff erentiation to defi ne the molecular basis of eff ector CTL differentiation <ref type="bibr" target="#b4">( 5,</ref><ref type="bibr" target="#b5">6 )</ref>.</p><p>The T-box transcription factors Eomesodermin (Eomes) and T-bet are needed for important aspects of eff ector and memory CTL diff erentiation <ref type="bibr" target="#b6">( 7 )</ref>. In uninfected mice, compound deletion of the Tbx21 (encoding T-bet) and eomesodermin genes is associated with a selective loss of CD8 + T cells with an IL-2R ␤ -high, memory phenotype <ref type="bibr" target="#b7">( 8 )</ref>. Mice defi cient for both T-bet and Eomes in T cells have impaired ex-pression of cytolytic mediators, manifest poor cytolytic activity, and fail to control acute lymphocytic choriomeningitis virus infection <ref type="bibr" target="#b8">( 9 )</ref>. Nevertheless, the specifi c roles of T-bet and Eomes in clonal expansion and CTL diff erentiation have not yet been resolved: in particular, it is not known whether these transcription factors function redundantly to control eff ector CD8 + T cell diff erentiation, and whether they do so directly by targeting specifi c eff ector cytokine and cytolytic genes.</p><p>Runx proteins, a family of three DNAbinding transcription factors, control thymocyte diff erentiation and the CD4/CD8 lineage decision <ref type="bibr">( 10 -13 )</ref>. Runx3 and perforin mRNA are expressed by double-positive (DP) thymocytes and CD8 + single-positive (SP) thymocytes but not in CD4 + SP cells <ref type="bibr" target="#b14">( 14 )</ref>. Although Runx3 is not expressed in naive CD4 + T cells, its expression is up-regulated during Th1 cell In contrast, granzyme B ( Gzmb ) mRNA was low or undetectable in naive T cells but was strongly up-regulated by day 2 after stimulation and increased progressively until day 6 ( <ref type="figure" target="#fig_0">Fig. 1, A and B )</ref>; similarly, granzyme B protein was expressed by day 4 and remained high until day 6 ( <ref type="figure" target="#fig_0">Fig. 1 E )</ref>. As expected, a small fraction of naive T cells expressed the cytokines IFN-␥ and TNF in response to stimulation, and this capacity increased signifi cantly in diff erentiated cells <ref type="figure" target="#fig_0">( Fig. 1 E</ref> ; see also <ref type="figure" target="#fig_1">Fig. 2 A )</ref>.</p><p>We evaluated antigen-dependent cytolytic function in a short-term assay in which target cell death was measured within 2 h <ref type="figure" target="#fig_0">( Fig. 1 F )</ref>. By limiting the duration of TCR stimulation, this strategy minimizes cytolysis secondary to new gene expression during the period of the assay. Naive T cells did not display signifi cant cytolytic function in this short-term assay (unpublished data), most likely because they express immature (unprocessed) forms of perforin and lack the capacity to degranulate <ref type="bibr" target="#b18">( 18,</ref><ref type="bibr" target="#b19">19 )</ref>. Even after activation for 2 or 4 d, the cells showed poor cytolytic activity ( <ref type="figure" target="#fig_0">Fig. 1 F )</ref>, in striking contrast to their capacity for effi cient cytokine production ( <ref type="figure" target="#fig_0">Fig. 1 E )</ref>. Only cells cultured until day 6 displayed robust cytotoxicity, as judged by their ability to induce apoptosis in a large number of target cells <ref type="figure" target="#fig_0">( Fig. 1 F )</ref>.</p><p>These results show that after a strong priming stimulus through TCRs and co-stimulatory receptors in vitro, granzyme B expression and the ability to produce eff ector cytokines are programmed early, whereas perforin expression and cytolytic function are induced later, during the phase of clonal expansion in IL-2. Therefore, the two major eff ector functions of CTL, cytokine production and cytolytic activity, are not intrinsically coregulated.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Distinct kinetics of T-bet and Eomes expression during CTL differentiation</head><p>The T-box transcription factors T-bet and Eomes have been linked to the regulation of genes encoding eff ector cytokines (e.g., Ifn g) and genes important for cytolytic function (e.g., Prf1 and GzmB ) <ref type="bibr" target="#b20">( 20 )</ref>. We investigated the kinetics of expression of these transcription factors in our in vitro cultures <ref type="figure" target="#fig_0">( Fig. 1, A -D )</ref>. T-bet mRNA and protein were not detectable in naive CD8 + T cells, but were strongly induced upon TCR priming (day 2) and remained expressed through day 6 of diff erentiation <ref type="figure" target="#fig_0">( Fig. 1</ref>, A and C ; quantifi ed in <ref type="figure" target="#fig_0">Fig. 1</ref>, B and D ). In contrast, Eomes expression was low or undetectable at both the mRNA and protein levels in naive CD8 + T cells, and TCR priming in culture had only a modest eff ect on its expression at day 2 <ref type="figure" target="#fig_0">( Fig. 1</ref>, A and C ). Strong induction of Eomes mRNA and protein was only observed at day 4 and later ( <ref type="figure" target="#fig_0">Fig. 1</ref>, A and C ). T-bet mRNA expression slightly preceded the expression of GzmB mRNA; similarly, Eomes mRNA and protein were expressed ‫ف‬ 1 d ahead of the reexpression of perforin mRNA and protein, respectively <ref type="figure" target="#fig_0">( Fig. 1, B</ref> </p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>and D ).</head><p>This detailed kinetic analysis suggested that, under our culture conditions, T-bet and Eomes contribute to distinct aspects of gene transcription during CTL diff erentiation. T-bet is required early for IFN-␥ production, and our data suggested diff erentiation, and Runx3 infl uences Th1 cell diff erentiation and function through direct regulation of the Il4 and Ifng cytokine genes <ref type="bibr" target="#b15">( 15,</ref><ref type="bibr" target="#b16">16 )</ref>. In contrast, all three Runx proteins are expressed in mature CD8 + T cells <ref type="bibr" target="#b9">( 10,</ref><ref type="bibr" target="#b11">12 )</ref>, and Runx3-deficient CD8 + T cells show reduced cytolytic activity <ref type="bibr" target="#b11">( 12,</ref><ref type="bibr" target="#b12">13 )</ref>. We therefore tested whether Runx3 infl uenced cytolytic T cell diff erentiation.</p><p>In this report, we show that Runx3 and T-box factors synergistically regulate CTL diff erentiation and function. T-bet is induced quickly upon TCR stimulation and is required for early programming of cytokine production <ref type="bibr" target="#b17">( 17 )</ref>, whereas Eomes is induced later during diff erentiation and sustains IFN-␥ expression. Runx3 is required for Eomes and perforin expression, and both Eomes and Runx3 bind at the Prf1 locus; in contrast, perforin expression is unaff ected in T-bet -defi cient cells. T cells lacking Runx3 show decreased expression of IFN-␥ and granzyme B, and Runx3 also binds the promoter regions of the Ifng and Gzmb genes. Collectively, these results provide evidence for a complex transcriptional network in which Runx3 is a primary regulator of Gzmb expression but synergizes with T-bet and Eomes, respectively, to promote transcription of the Ifng and Prf1 genes.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>RESULTS AND DISCUSSION A cell culture system to monitor effector CTL differentiation</head><p>We used a simple cell culture system to examine the kinetics of eff ector gene expression during CD8 + T cell diff erentiation. Naive CD8 + T cells from P14 TCR transgenic mice were activated for 2 d with anti-CD3 and anti-CD28 or with splenic APCs in the presence of Gp33 peptide, and were cultured in media containing 100 U/ml of recombinant human IL-2 (rhIL-2). We used TCR transgenic mice for these experiments because they provide a reliable source of CD8 + T cells that are truly naive; however, we chose not to stimulate cells with antigen in most experiments so as to avoid contamination with proteins and nucleic acids derived from APCs. There were only minor diff erences in gene expression during diff erentiation induced by antigen/APC versus anti-CD3/ anti-CD28, and the major conclusions presented in this report are the same for both activating conditions.</p><p>Under our culture conditions, activated CD8 + T cells expanded exponentially and accumulated for &gt; 8 d. We limited our analysis to the fi rst 6 -8 d after activation, a period that coincides with clonal expansion of CD8 + T cells after activation in vivo.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Distinct expression kinetics of perforin and granzyme B during CTL development in culture</head><p>Our experiments revealed clear diff erences in the kinetics of perforin, granzyme B, and cytokine expression during CD8 + T cell activation <ref type="figure" target="#fig_0">( Fig. 1</ref> ). Naive T cells showed detectable expression of perforin mRNA as well as perforin protein <ref type="figure" target="#fig_0">( Fig. 1</ref>, A -D ). Relative to its expression in naive T cells, perforin ( Prf1 ) mRNA expression did not increase appreciably at day 2 but showed a reproducible decrease at day 4, followed by robust reexpression between days 4 and 8 <ref type="figure" target="#fig_0">( Fig. 1, A -D )</ref>. that Eomes might not function during this early period but rather might contribute later to the control of perforin expression. Our data seemed most consistent with a model in which TCR signals induce T-bet, which in turn induces IFN-␥ <ref type="bibr" target="#b17">( 17 )</ref> and possibly granzyme B; subsequently, Eomes is induced during the period of clonal expansion in IL-2 and activates perforin expression.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Perforin and granzyme B expression are not appreciably regulated by T-bet</head><p>To test the model outlined in the previous paragraph directly, we compared the expression of IFN-␥ , perforin, and granzyme B in CD8 + T cells from WT and Tbx21 (T-bet)-deficient mice. As expected <ref type="bibr" target="#b17">( 17,</ref><ref type="bibr" target="#b21">21 )</ref>, naive Tbx21 Ϫ / Ϫ CD8 + T cells produced IFN-␥ poorly upon activation <ref type="figure" target="#fig_1">( Fig. 2 A )</ref>. Notably, this deleterious eff ect of T-bet defi ciency was only observed in diff erentiating CD8 + T cells until day 4 of culture but was almost completely mitigated by day 6 ( <ref type="figure" target="#fig_1">Fig. 2 A )</ref>. This most likely refl ected compensation by Eomes, which was strongly induced between days 4 and 6 ( <ref type="figure" target="#fig_0">Fig. 1</ref> ). In contrast, T-bet -defi cient T cells cultured for 6 d showed no defect in perforin mRNA expression ( <ref type="figure" target="#fig_1">Fig. 2 B</ref> , compare lanes 1 and 4). We consistently observed a modest reduction in GzmB mRNA in T-bet -defi cient T cells ( <ref type="figure" target="#fig_1">Fig. 2 B</ref> , compare lanes 1 and 4), which did not translate into a decrease in expression of granzyme B protein <ref type="figure" target="#fig_1">( Fig. 2 C )</ref>.</p><p>To examine the role of Eomes, we transduced naive CD8 + T cells from WT and Tbx21 Ϫ / Ϫ mice with retroviruses containing internal ribosome entry site (IRES) -GFP that were either empty or encoded a strongly transactivating version of Eomes (Eo-VP16) ( 8 ), and expanded them for 6 d under our culture conditions. Eo-VP16, but not the empty GFP retrovirus, increased perforin expression in both WT and T-betdefi cient CD8 + T cells ( <ref type="figure" target="#fig_1">Fig. 2 B</ref> , lanes 2, 3, 5, and 6). As expected, Eo-VP16 also rescued the early defect in IFN-␥ production observed in T-bet -defi cient CD8 + T cells <ref type="figure" target="#fig_1">( Fig. 2  D )</ref>. However, Eo-VP16 did not induce GzmB mRNA expression in either WT or T-bet -defi cient cells; thus, the partial T-bet dependence of GzmB mRNA expression cannot be compensated for by Eo-VP16.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Runx3 controls multiple aspects of the CTL differentiation program, in part through induction of Eomes</head><p>Because Runx3 is highly expressed in peripheral CD8 + T cells, and because of the T-bet-Runx3 cooperation we observed earlier in CD4 + T cells ( 15 ), we examined the role of Runx3 in eff ector CTL diff erentiation. We isolated CD8 + T cells from Runx3 Ϫ / Ϫ (KO) mice of the outbred ICR background and their WT Runx3 +/+ littermates by positive selection with anti-CD8 magnetic beads (Figs. S1 and S2, available at http://www.jem.org/cgi/content/full/ </p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>BRIEF DEFINITIVE REPORT</head><p>To test this hypothesis, we used chromatin immunoprecipitation (ChIP) assays to ask whether Eomes and Runx3 bound regulatory regions of the Prf1 , Ifng , and Gzmb genes <ref type="figure" target="#fig_2">( Fig. 3 D )</ref>. Both proteins associated with gene regulatory regions in diff erentiated CTLs. Runx3 bound to the Prf1 and Gzmb transcription start sites (TSS); to a known IL-2 responsive enhancer located near Ϫ 1 kb of the Prf1 gene ( 23 ); to the distal CTLspecifi c DNase I hypersensitive site 9 in the Prf1 locus <ref type="bibr" target="#b24">( 24 )</ref>; to the Ifng promoter near the TSS, as previously reported for Th1 cells <ref type="bibr" target="#b9">( 10 )</ref>; and to several DNase I hypersensitive sites in the Ifng locus ( <ref type="figure" target="#fig_2">Fig. 3</ref> D and not depicted) <ref type="bibr" target="#b25">( 25 )</ref>. Eomes bound primarily to the Prf1 TSS and the Ϫ 1 kb enhancer; this binding was substantially greater than that observed at the promoter of the Il2rb gene, a known direct target of Eomes <ref type="bibr" target="#b7">( 8 )</ref>, and comparable to that observed at the Ifng TSS, a known target of T-box proteins in both Th1 and CD8 + T cells ( <ref type="figure" target="#fig_2">Fig. 3 D )</ref>  <ref type="bibr" target="#b17">( 17 )</ref>.</p><p>To determine whether Runx3 controlled the expression of CTL eff ector genes through its induction of Eomes, we retrovirally expressed Runx3 and Eo-VP16 in CD8 + T cells from Runx3 Ϫ / Ϫ mice. Because of the limited number of CD8 + T cells in these mice, and because we saw no diff erence between Runx3 Ϫ / Ϫ CD8 + CD4 Ϫ SP and CD8 + CD4 + DP cells in our previous experiments, we used total Runx3 Ϫ / Ϫ CD8 + T cells without further fractionation as recipients for retroviral transduction. Reconstitution of Runx3 Ϫ / Ϫ CD8 + T cells with Runx3 restored expression of Eomes as well as perforin, granzyme B, and IFN-␥ <ref type="figure" target="#fig_4">( Fig. 4, A and B )</ref>. In addition, Runx3 Ϫ / Ϫ T cells showed a jem.20081242/DC1). Strikingly, Runx3 Ϫ / Ϫ CD8 + T cells were strongly impaired in their ability to diff erentiate into eff ector CTLs, as judged by expression of perforin, granzyme B, and IFN-␥ <ref type="figure" target="#fig_2">( Fig. 3 )</ref>. Compared with WT T cells, perforin mRNA and protein expression were essentially undetectable in Runx3 Ϫ / Ϫ T cells at day 6 of culture <ref type="figure" target="#fig_2">( Fig. 3,  A and B )</ref>. Runx3 Ϫ / Ϫ T cells also had no detectable Eomes expression; in contrast, T-bet expression was unimpaired <ref type="figure" target="#fig_2">( Fig. 3 A )</ref>. Furthermore, Runx3 was required for maximal production of IFN-␥ , but not TNF or IL-2, by CD8 + T cells restimulated at day 6 ( <ref type="figure" target="#fig_2">Fig. 3 C )</ref>.</p><p>We previously reported that Th1 cell diff erentiation was regulated through a feed-forward loop in which T-bet is upregulated early and induces Runx3, after which T-bet and Runx3 cooperate to induce IFN-␥ and silence IL-4, thus promoting stable diff erentiation toward the Th1 lineage <ref type="bibr" target="#b15">( 15,</ref><ref type="bibr" target="#b22">22 )</ref>. Because (a) Runx3 appeared necessary for Eomes induction <ref type="figure" target="#fig_2">( Fig. 3 A )</ref>, (b) the kinetics of Eomes expression paralleled those of perforin expression <ref type="figure" target="#fig_1">( Fig. 2 )</ref>, and (c) overexpression of Eo-VP16 in either WT or T-bet -defi cient T cells led to an increase in both perforin and IFN-␥ expression <ref type="figure" target="#fig_1">( Fig. 2, B and D )</ref>, we asked whether CTL diff erentiation was also potentially regulated by a feed-forward loop involving these same two classes of Runx and T-box transcription factors. Specifi cally, we asked whether Runx3, which was necessary for Eomes induction, then cooperated with Eomes to regulate transcription of the effector CTL markers perforin, IFN-␥ , and granzyme B.  </p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Runx3 and T-box factors control a complex program of transcriptional regulation during CTL differentiation</head><p>Collectively, these data provide evidence that Runx3, together with T-box factors, orchestrates a complex program of transcriptional regulation in diff erentiating CTL <ref type="figure" target="#fig_4">( Fig. 4 C )</ref>. Runx3 is present in naive CD8 + T cells before activation <ref type="bibr" target="#b11">( 12 )</ref>. It represses Runx1 and has a positive role in the induction of Eomes, granzyme B, perforin, and IFN-␥ . Runx3 binds to promoters and putative regulatory regions of the latter three genes, suggesting a direct eff ect on gene expression. Additional experiments are needed to determine whether Eomes and Runx1 are also direct target genes of Runx3. compensatory up-regulation of Runx1, which was suppressed upon reconstitution with Runx3, indicating that Runx1 is a target of repression by Runx3. Notably, Eo-VP16 did not up-regulate perforin expression when expressed in Runx3 Ϫ / Ϫ cells, even though it restored the capacity to induce IFN-␥ expression upon TCR restimulation <ref type="figure" target="#fig_4">( Fig. 4, A and B )</ref>. This result suggests strongly that perforin expression requires Runx3 and Eomes.</p><p>As expected from their defect in perforin and granzyme B expression, Runx3 Ϫ / Ϫ CD8 + T cells showed defective cytolytic activity in a mixed lymphocyte reaction <ref type="bibr" target="#b11">( 12 )</ref>. However, TCRstimulated Runx3 Ϫ / Ϫ CD8 + cells were as eff ective as WT cells in killing tumor cells in a redirected CTL assay <ref type="bibr" target="#b11">( 12 )</ref>. Furthermore, CD8 + cells from the peritoneal cavity of Runx3 Ϫ / Ϫ mice immunized with certain tumor cells eff ectively killed these targets <ref type="bibr" target="#b12">( 13 )</ref>. Therefore, although activation of the perforin/granzyme B machinery is defective in Runx3 Ϫ / Ϫ CD8 + cells, these </p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>BRIEF DEFINITIVE REPORT</head><p>produced by the Groner laboratory. The following antibodies were used for immunoblotting: antiperforin (Abcam), anti-Eomes (Abcam), and anti -Pol-II (Santa Cruz Biotechnology, Inc.). The T-bet antibody was provided by L. Glimcher (Harvard School of Public Health, Boston, MA).</p><p>The following reagents were used for the experiments presented in this report: Annexin V -FITC Apoptosis Detection Kit (BD), CD8 Negative Isolation Kit (Invitrogen), CD8 MicroBeads (Miltenyi Biotec), and SYBR Green PCR Core Reagents (Applied Biosystems). The Gp33 peptide (KAVYNFATC) was synthesized by the Tufts University Core Facility, and 10 mM of stock solutions was prepared in DMSO.</p><p>Isolation and culture of primary CD8 + T cells. CD8 + T cells from 4 -8wk-old Tcra Ϫ / Ϫ × P14 TCR transgenic (Taconic), C57BL/6J WT, or Tbx21 Ϫ / Ϫ (The Jackson Laboratory) mice were purifi ed ( &gt; 95% purity) by negative selection (Invitrogen) from pooled spleen and lymph node cells. CD8 + T cells from Runx3 Ϫ / Ϫ mice on the ICR background were purifi ed by positive selection (Miltenyi Biotec). All mice were maintained in specifi c pathogen-free barrier facilities and used according to protocols approved by the Immune Disease Institute and the Harvard Medical School Animal Care and Use Committees. For stimulation, purifi ed CD8 + T cells were cultured at 10 6 cells/ml (10 ml) in T25 fl asks coated with 1 μ g/ml each of anti-CD3 (clone 2C11) and anti-CD28 (clone 37.51) by pretreatment with 300 μ g/ml goat anti -hamster IgG. After 48 h, cells were removed from the TCR stimulation and recultured at a concentration of 5 × 10 5 cells/ml in media supplemented with 100 U/ml rhIL-2. Every 24 h, viable cells were counted and readjusted to 5 × 10 5 cells/ml with fresh media containing the corresponding amount of rhIL-2.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Isolation of CD8 + T cells from Runx3</head><p>؊ / ؊ mice. Runx3-defi cient T cells fail to silence CD4 expression normally <ref type="figure" target="#fig_0">(Fig. S1)</ref>  <ref type="bibr" target="#b11">( 12,</ref><ref type="bibr" target="#b12">13 )</ref>. We therefore further fractionated the positively selected CD8 + T cells from Runx3 KO mice into CD8 + CD4 Ϫ SP or CD8 + CD4 + DP cells by separation using anti-CD4 magnetic beads. This yielded a Runx3 KO SP " enriched " population that contained 75% CD8 + CD4 Ϫ cells and a KO DP enriched population that contained 85% CD8 + CD4 + cells <ref type="figure" target="#fig_0">(Fig. S1)</ref>. The cells were stimulated with anti-CD3 + anti-CD28 for 2 d before removing them from the TCR stimulus and culturing them in media containing 100 U/ml IL-2. As previously reported, TCR-induced proliferation of Runx3 Ϫ / Ϫ CD8 + T cells was severely impaired, irrespective of CD4 expression ( <ref type="figure" target="#fig_0">Fig. S1)</ref>  <ref type="bibr" target="#b11">( 12,</ref><ref type="bibr" target="#b12">13 )</ref>. However, the Runx3 Ϫ / Ϫ cells showed cell-surface expression patterns indicative of activated cells, including up-regulation of CD25 and CD69 <ref type="figure" target="#fig_0">(Fig. S1</ref>). As expected from their ability to up-regulate CD25, Runx3 Ϫ / Ϫ CD8 + T cells responded to IL-2 supplementation after day 2 and effi ciently expanded until day 6 of the culture period, albeit at slower rates compared with WT cells <ref type="figure" target="#fig_0">(Fig. S1)</ref>. Although a fraction of the KO DP cells silenced CD4 expression after activation, the ratio of SP/DP cells in each enriched population remained constant thereafter, and we did not observe any major diff erences between these two populations throughout the culture period, indicating that in terms of eff ector CTL diff erentiation and under our culture conditions, Runx3 Ϫ / Ϫ CD8 + T cells that also coexpress CD4 are indistinguishable from those that do not. The data presented in <ref type="figure" target="#fig_1">Fig. S2</ref> are from Runx3 KO SP cells, whereas those shown in <ref type="figure" target="#fig_2">Figs.  3 and 4</ref> are from total Runx3 KO CD8 cells.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>FACS-based cytotoxicity assay.</head><p>To measure cytotoxicity, EL4 thymoma target cells were loaded with 0 or 1 μ M Gp33 peptide for 2 h before a 2-h coincubation with P14 CD8 + T cells at the eff ector-to-target ratios indicated in the fi gures in 96-well round-bottom plates. After the coincubation period, cells were stained with Annexin V -FITC and anti-CD8 -allophycocyanin. Data analysis was performed with FlowJo software (Tree Star, Inc.); EL4 target cells (CD8-negative events) were gated, and the percentage of Annexin V + target cells was determined.</p><p>Cytokine and surface marker staining. To assess cytokine production, cells were restimulated with 10 nM PMA + 1 μ M ionomycin for 6 h (unless indicated otherwise in the fi gures), and intracellular cytokine stains were performed as previously described <ref type="bibr" target="#b28">( 28 )</ref>. To detect expression of surface molecules, Surprisingly, Runx3 contributed to the optimal expression of TNF, IL-2, and IFN-␥ at day 4 <ref type="figure" target="#fig_1">(Fig. S2)</ref>. For TNF and IL-2, the requirement for Runx3 subsides by day 6 <ref type="figure" target="#fig_2">( Fig. 3 C )</ref>, possibly because of compensation by Runx1, which is derepressed in Runx3 Ϫ / Ϫ cells <ref type="figure" target="#fig_4">( Fig. 4 A )</ref>. Runx3 continues to be required for IFN-␥ expression even at day 6, perhaps because of its role in the induction of Eomes expression ( <ref type="figure" target="#fig_4">Fig. 4 A )</ref>.</p><p>An unexpected fi nding was that the two T-box transcription factors, T-bet and Eomes, are up-regulated with very different kinetics in CD8 + T cells under our culture conditions and have nonredundant roles in the subsequent expression of key eff ector proteins <ref type="figure" target="#fig_4">( Fig. 4 C )</ref>. T-bet is needed early to confer on activated CD8 + T cells the competence to produce IFN-␥ upon restimulation, but its function is less important at later times. Eomes, which is induced late and functions downstream of Runx3, may substitute for T-bet in promoting the acute expression of IFN-␥ in restimulated CTLs <ref type="bibr" target="#b7">( 8 )</ref>. Indeed, T-bet and Eomes both contribute to perforin expression in NK cells <ref type="bibr" target="#b7">( 8,</ref><ref type="bibr" target="#b26">26 )</ref>, and Eomes induces granzyme B as eff ectively as T-bet in developing Th2 cells <ref type="formula">7</ref>; thus, the relative roles of these Tbox transcription factors vary depending on cell type.</p><p>Surprisingly, however, Eomes and T-bet appeared nonredundant in their ability to induce two other markers of CTL function, Prf1 and Gzmb <ref type="figure" target="#fig_4">( Fig. 4 C )</ref>. Rather, T-bet and Eomes were involved in regulating granzyme B and perforin expression, respectively: up-regulation of T-bet and Eomes mRNA and protein closely preceded up-regulation of Gzmb and Prf1 mRNA and protein, respectively. T-bet had no role in perforin expression under our culture conditions, and Eo-VP16 did not aff ect granzyme B expression when expressed in T-bet Ϫ / Ϫ or Runx3 Ϫ / Ϫ cells. Because conventional Eomes-defi cient mice die before precursor cells can be isolated for bone marrow transfers <ref type="bibr" target="#b27">( 27 )</ref> and because T cells conditionally defi cient in Eomes have only recently been described ( 9 ), we were unable to introduce Runx3 into Eomes-defi cient CD8 + T cells to test formally whether Eomes cooperated with Runx3 to induce perforin expression.</p><p>Collectively, our data are consistent with a transcriptional network in which preexisting Runx3 cooperates with the induced T-box factors T-bet and Eomes and IL-2R ␤ signals (unpublished data) to orchestrate CTL diff erentiation <ref type="figure" target="#fig_4">( Fig. 4 C )</ref>. Our data recall the " feed-forward " interaction between T-bet and Runx3 that we previously described in CD4 + (Th1) T cells ( 15 ) but are distinct in two respects: in diff erentiating Th1 cells, T-bet is induced by TCR signals and IFN-␥ , and in turn induces Runx3 <ref type="bibr" target="#b15">( 15 )</ref>, whereas in diff erentiating CD8 + T cells, preexisting Runx3 is required to induce the T-box transcription factor Eomes. Whole-genome experiments in these and other systems will be required to establish whether cooperation between T-box and Runx family transcription factors is a general feature of cellular diff erentiation programs.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>MATERIALS AND METHODS</head><p>Antibodies and reagents. The following antibodies used for intracellular or surface stains were obtained from eBioscience: anti -IL-2, anti -IFN-␥ , anti-TNF, anti -granzyme B, anti-CD8, anti-CD25, and anti-CD44. Anti-CD69 was purchased from BD. For ChIP experiments, the anti-Eomes antibody was obtained from Abcam and the anti-Runx3 antibody was sion in 100 U/ml IL-2 with lysis buff er (50 mM Tris [pH 7.5], 150 mM NaCl, 10% glycerol, 5 mM EDTA, 1% NP-40) by resuspending samples in 10 μ l per 10 6 cells and incubating on ice for 30 min in the presence of protease inhibitors. Immunoblot analysis was performed with the antibodies indicated in the fi gures after SDS-PAGE (10 -30 μ g of total protein was loaded per well). Quantifi cation of detected protein was performed with an Intelligent Dark Box unit (LAS-3000; Fujifi lm) and normalized for loading with the amount of RNA Pol-II detected in each lane.</p><p>Online supplemental material. <ref type="figure" target="#fig_0">Fig. S1</ref> shows the characterization of peripheral CD8 + T cells from Runx3 Ϫ / Ϫ mice. <ref type="figure" target="#fig_1">Fig. S2</ref> shows eff ector protein expression by Runx3 WT and KO cells at day 4 of in vitro culture. Primer sequences used for ChIP experiments are shown in <ref type="table">Table S1</ref>. Online supplemental material is available at http://www.jem.org/cgi/content/full/jem.20081242/DC1. cells were washed in PBS, resuspended in FACS wash buff er (3% FBS, 0.1% sodium azide, 30 mM Hepes, 1 × PBS) containing the antibodies indicated in the fi gures at previously optimized concentrations, incubated for 15 min at room temperature (RT), washed, and resuspended in 2% formaldehyde fi xative solution before acquisition on a FACSCalibur (BD).</p><p>Retroviral transduction of primary CD8 + T cells. For transduction experiments, viral supernatants were generated by calcium phosphate transfection of Phoenix cells and concentration by overnight centrifugation at 6,000 g . At ‫ف‬ 42 h after the initial TCR activation of 10 6 CD8 + T cells per well in 12-well plates, the culture media was removed and replaced with complete media supplemented with 8 μ g/ml polybrene containing fresh plus concentrated virus. The plates were centrifuged at 700 g for 1 h at RT before returning to 37 ° C for an additional 5 h. Retroviral constructs for Eomes-VP16 and the MIG control empty vector were a gift from S.L. Reiner (University of Pennsylvania, Philadelphia, PA) ( 8 ).</p><p>ChIP and real-time PCR analysis. 20 × 10 6 CD8 + T cells per immunoprecipitation were fi xed by adding a 1/10th volume of fi xation solution (11.1% formaldehyde, 100 mM NaCl, 1 mM EDTA, 0.5 mM EGTA, 50 mM Hepes) to 1 volume of culture media and were incubated for 10 or 30 min at RT. Fixation was stopped with 120 mM glycine on ice for 5 min. Fixed cells were washed 2 × with cold PBS, 1 × with cold solution I (10 mM Tris [pH 7.5], 10 mM EDTA, 0.5 mM EGTA, 1% Triton X-100), and 1 × with cold solution II (10 mM Tris [pH 7.5], 1 mM EDTA, 0.5 mM EGTA, 200 mM NaCl). After washes, cell pellets were resuspended at 40 × 10 6 cells/ml in ChIP lysis buff er (150 mM NaCl, 25 mM Tris [pH 7.5], 1% Triton X-100, 0.1% SDS, 0.5% deoxycholate plus protease and phosphatase inhibitors), and chromatin was sheared with a sonicator to yield 0.5 -1-kb DNA fragments. After preclearing the sheared chromatin with protein Asepharose beads and removing 5% as input chromatin, immunoprecipitation was performed by adding optimized antibody amounts (per 20 × 10 6 cell equivalents: 2.5 μ g anti-Eomes, 1:100 dilution anti-Runx3), followed by overnight incubation at 4 ° C; protein A -sepharose beads were added for the last 3 h of the incubation period. Beads were washed 2 × with RIPA buff er (50 mM Tris [pH 8], 150 mM NaCl, 1 mM EDTA, 1% NP-40, 0.1% SDS, 0.5% deoxycholate), 1 × with high salt buff er (50 mM Tris [pH 8], 500 mM NaCl, 1 mM EDTA, 1% NP-40, 0.1% SDS), and 1 × with TE buff er. After the last wash, DNA was eluted by resuspending the beads in elution buff er (1% SDS, 100 mM NaHCO 3 ). Both input and ChIP chromatin were then treated with RNase A (5 μ g total) for 1 h at 37 ° C, followed by the addition of proteinase K (100 μ g total) and overnight incubation at 65 ° C to reverse cross-linking. DNA was then purifi ed with QIAquick columns (Gel Extraction Kit; QIAGEN) according to the manufacturer ' s instructions and resuspended in a 50-μ l volume. For real-time PCR detection of immunoprecipitated targets using the SYBR Green PCR Kit, a standard curve was obtained with serial dilutions of input DNA for each sample, and 1 μ l ChIP DNA was used per PCR reaction (performed in duplicates). Melt curves and agarose gels were analyzed to ensure amplifi cation of specifi c target sequences. Refer to <ref type="table">Table  S1</ref> (available at http://www.jem.org/cgi/content/full/jem.20081242/DC1) for a list of primer sets. The data are presented as the number of immunoprecipitated target sequences relative to input chromatin, assuming two copies of target sequence per cell equivalent used for the ChIP.</p><p>Northern and Western blot analyses. RNA isolation and Northern blot analysis was performed as previously described <ref type="bibr" target="#b29">( 29 )</ref>. In brief, 10 μ g of total RNA was loaded per lane and transferred to positively charged nylon membranes (Hybond-N + ; GE Healthcare), which was confi rmed by ethidium bromide staining of ribosomal RNA species on the membrane. Membranes were hybridized with 1 ng/ml ␣ -[ 32 P]dCTP -labeled trichloroacetic acid precipitable probe in ExpressHyb hybridization buff er (Clontech Laboratories, Inc.). All cDNA probes were confi rmed to have the appropriate singlecopy specifi city under these conditions using genomic Southern blot analysis. Band intensities were acquired by phosphorimaging analysis.</p><p>For Western analysis, whole-cell protein lysates were obtained from CD8 + T cells at the time points indicated in the fi gures during clonal expan-</p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>Figure 1 .</head><label>1</label><figDesc>Kinetics of gene expression during CD8 + T cell differentiation. (A) Kinetics of Prf1 , Gzmb , Tbx21 (T-bet), and Eomes mRNA expression in differentiating P14 CD8 + T cells analyzed by Northern blotting. RNA from day 7 Th1 cells was used as a control. Sizes of mRNA transcripts are indicated. (B) Quantifi cation of relative mRNA amounts by phosphorimager analysis. (C) Kinetics of protein expression in differentiating P14 CD8 + T cells analyzed by immunoblotting. Sizes of protein bands are indicated. (D) Relative protein amounts quantifi ed from the Western blots. (E) Intracellular staining for granzyme B, IFN-␥ , and TNF. Granzyme B staining was specifi c relative to an isotype control (not depicted). Cells were restimulated with PMA and ionomycin for 4 h. (F) FACS-based assay to measure cytolytic activity of P14 CD8 + T cells against EL4 targets loaded with 0 ( Ϫ ) or 1 (+) μ M Gp33 peptide (effector-to-target ratio = 5:1). Percentage of Annexin V + (apoptotic) target cells in the CD8-negative EL4 target population (dot plots) was determined (histograms). Cytolytic activity was blocked by incubation with 2 mM EGTA (not depicted), confi rming involvement of the granule exocytosis (perforingranzyme B) pathway. Data are representative of at least fi ve (A -E) or three (F) independent experiments.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head>Figure 2 .</head><label>2</label><figDesc>Regulation of perforin, granzyme B, and IFN-␥ expression by T-bet and Eomes in differentiating CTLs. (A) IFN-␥ expression by WT ( Tbx21 +/+ ) and T-bet -defi cient ( Tbx21 Ϫ / Ϫ ) T cells. Naive CD8 + T cells, or cells activated and cultured for 4 or 6 d, were restimulated with PMA and ionomycin for 6 h, and IFN-␥ expression was assessed by intracellular staining. Numbers show the percentage of IFN-␥ + cells. (B) Northern blot analysis of Prf1 and GzmB mRNA expression in WT or T-bet -defi cient CD8 + T cells activated and either left uninfected (uninf) or transduced with retroviruses expressing Eomes-VP16 (Eo-VP16) or an empty IRES-GFP cassette (GFP). Total cellular RNA was analyzed on day 6 of culture. The frequency of transduced cells in the cultures was equivalent for both constructs ( ‫ف‬ 65 -70% GFP + cells; not depicted). (C) Granzyme B and IFN-␥ expression by Tbx21 +/+ and Tbx21 Ϫ / Ϫ T cells analyzed in restimulated cells that had been cultured for 5 d. (D) IFN-␥ production by cells transduced with Eo-VP16 or control (GFP) retroviruses (RV) measured on day</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_2"><head>Figure 3 .</head><label>3</label><figDesc>Key role for Runx3 in effector CTL differentiation. (A) Western analysis of Runx3, Eomes, T-bet, and perforin expression in Runx3 +/+ versus Runx3 Ϫ / Ϫ CD8 + SP T cells differentiated for 6 d. ␤ -Actin was used as a loading control. (B) Northern blot analysis of Prf1 mRNA expression in Runx3 +/+ versus Runx3 Ϫ / Ϫ CD8 + T cells differentiated for 6 d. ␤ -Actin was used as a loading control. (C) Expression of granzyme B, IFN-␥ , TNF, and IL-2 by resting or restimulated (6 h) Runx3 +/+ versus Runx3 Ϫ / Ϫ CD8 + SP T cells differentiated for 6 d. The vertical gray line indicates the granzyme B MFI for WT GFP + cells. Results in A -C are representative of two independent experiments. (D) ChIP analysis of binding of endogenous Runx3 and Eomes to the Prf1 locus. Enrichment of the indicated genomic regions was evaluated by real-time PCR of DNA from immunoprecipitated and input chromatin. The data are the means of duplicate measurements from two chromatin preparations from two independent CD8 + T cell differentiations. The effi ciency of recovery of input for the Ϫ 1-kb region of Prf1 was 0.97% for the Runx3 ChIP and 0.5% for the Eomes ChIP.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_3"><head></head><label></label><figDesc>cells are not entirely devoid of cytolytic activity and could still eff ectively kill targets, possibly by alternative mechanisms such as the Fas -Fas ligand pathway.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_4"><head>Figure 4 .</head><label>4</label><figDesc>Runx3 controls Eomes, perforin, granzyme B, and IFN-␥ expression in effector CTLs. Runx3 +/+ or Runx3 Ϫ / Ϫ CD8 + T cells were activated and transduced with retroviruses bearing an empty IRES-GFP cassette (GFP) or also encoding Eomes-VP16 (Eo-VP16) or Myc-Runx3 (Runx3). The frequency of transduced cells in the cultures was equivalent for all constructs ( ‫ف‬ 75 -90% GFP + cells; not depicted). (A) Protein expression in whole-cell extracts (day 6) was analyzed by immunoblotting. Overexpression of Eomes-VP16 cannot be detected with the Eomes antibody, as the C-terminal epitope is within the region that has been replaced with the VP16 transactivation domain. (B) Expression of granzyme B and IFN-␥ after culture for 6 d and restimulation for 4 h with PMA and ionomycin was determined by intracellular staining. The percentage of positively stained cells is shown above the gate; the mean fl uorescence intensity (MFI) of granzyme B staining for the total population is shown below the gate. The vertical gray lines indicate the MFI for WT GFP + cells. Results are representative of at least two independent experiments. (C) Schematic diagram of the transcriptional network involving Runx3 and T-box factors. T-bet is induced by TCR signals and is essential for early IFN-␥ expression. Runx3 is present in naive CD8 + T cells and represses Runx1 and induces Eomes, perforin, granzyme B, and IFN-␥ expression. Eomes may participate in sustaining late IFN-␥ expression, whereas Runx3 and Eomes (but not T-bet) may cooperate to activate perforin expression. The dotted line indicates the partial effect of T-bet defi ciency on Gzmb mRNA but not granzyme B protein expression.</figDesc></figure>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" n="4">after 6 h of restimulation with PMA and ionomycin. Numbers show the percentage of GFP + IFN-␥ + cells. Results are representative of three (A and C) or two (B and D) independent experiments.</note>
		</body>
		<back>

			<div type="acknowledgement">
<div xmlns="http://www.tei-c.org/ns/1.0"><p>We thank S. Reiner for providing the Eomes-VP16 expression plasmid and members of the Rao laboratory for helpful discussions.</p><p>This work was supported by National Institutes of Health grants CA42471 and AI44432 to A. Rao, and Israel Science Foundation grants to Y. Groner. M.E. Pipkin is supported by National Cancer Institute postdoctoral fellowship F32 CA126247-01. F. Cruz-Guilloty was supported by a Ford Foundation Predoctoral Fellowship. I.M. Djuretic and F. Cruz-Guilloty are both predoctoral fellows of the Ryan Foundation.</p><p>The authors have no confl icting fi nancial interests.</p></div>
			</div>

			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0" />			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">CD8+ T Cell Effector Mechanisms in Resistance to Infection</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">John</forename><forename type="middle">T</forename><surname>Harty</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Amy</forename><forename type="middle">R</forename><surname>Tvinnereim</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Douglas</forename><forename type="middle">W</forename><surname>White</surname></persName>
		</author>
		<idno type="DOI">10.1146/annurev.immunol.18.1.275</idno>
		<idno type="PMID">10837060</idno>
	</analytic>
	<monogr>
		<title level="j">Annual Review of Immunology</title>
		<title level="j" type="abbrev">Annu. Rev. Immunol.</title>
		<idno type="ISSN">0732-0582</idno>
		<idno type="ISSNe">1545-3278</idno>
		<imprint>
			<biblScope unit="volume">18</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="275" to="308" />
			<date type="published" when="2000-04" />
			<publisher>Annual Reviews</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">Delivering the kiss of death: progress on understanding how perforin works</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">E</forename><surname>Pipkin</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Lieberman</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.coi.2007.04.011</idno>
		<idno type="PMID">17433871</idno>
	</analytic>
	<monogr>
		<title level="j">Current Opinion in Immunology</title>
		<title level="j" type="abbrev">Current Opinion in Immunology</title>
		<idno type="ISSN">0952-7915</idno>
		<imprint>
			<biblScope unit="volume">19</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="301" to="308" />
			<date type="published" when="2007-06" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">Effector and Memory CTL Differentiation</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Matthew</forename><forename type="middle">A</forename><surname>Williams</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Michael</forename><forename type="middle">J</forename><surname>Bevan</surname></persName>
		</author>
		<idno type="DOI">10.1146/annurev.immunol.25.022106.141548</idno>
		<idno type="PMID">17129182</idno>
	</analytic>
	<monogr>
		<title level="j">Annual Review of Immunology</title>
		<title level="j" type="abbrev">Annu. Rev. Immunol.</title>
		<idno type="ISSN">0732-0582</idno>
		<idno type="ISSNe">1545-3278</idno>
		<imprint>
			<biblScope unit="volume">25</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="171" to="192" />
			<date type="published" when="2007-04" />
			<publisher>Annual Reviews</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">Programming, demarcating, and manipulating CD8+ T-cell memory</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Vladimir</forename><forename type="middle">P</forename><surname>Badovinac</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">John</forename><forename type="middle">T</forename><surname>Harty</surname></persName>
		</author>
		<idno type="DOI">10.1111/j.0105-2896.2006.00384.x</idno>
		<idno type="PMID">16824118</idno>
		<idno type="ark">ark:/67375/WNG-Z1ZFM4L8-R</idno>
		<idno type="istexId">C222D70E998D9AA3704FEDEA5B4CA825E5915B2D</idno>
	</analytic>
	<monogr>
		<title level="j">Immunological Reviews</title>
		<title level="j" type="abbrev">Immunol Rev</title>
		<idno type="ISSN">0105-2896</idno>
		<idno type="ISSNe">1600-065X</idno>
		<imprint>
			<biblScope unit="volume">211</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="67" to="80" />
			<date type="published" when="2006-06" />
			<publisher>Wiley</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">REGULATION OF TH2 DIFFERENTIATION AND Il4 LOCUS ACCESSIBILITY</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><forename type="middle">Mark</forename><surname>Ansel</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ivana</forename><surname>Djuretic</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Bogdan</forename><surname>Tanasa</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Anjana</forename><surname>Rao</surname></persName>
		</author>
		<idno type="DOI">10.1146/annurev.immunol.23.021704.115821</idno>
		<idno type="PMID">16551261</idno>
	</analytic>
	<monogr>
		<title level="j">Annual Review of Immunology</title>
		<title level="j" type="abbrev">Annu. Rev. Immunol.</title>
		<idno type="ISSN">0732-0582</idno>
		<idno type="ISSNe">1545-3278</idno>
		<imprint>
			<biblScope unit="volume">24</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="607" to="656" />
			<date type="published" when="2006-04" />
			<publisher>Annual Reviews</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">T Helper Cell Differentiation: Regulation by cis Elements and Epigenetics</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Gap</forename><forename type="middle">Ryol</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Sean</forename><forename type="middle">T</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Charalampos</forename><forename type="middle">G</forename><surname>Spilianakis</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Patrick</forename><forename type="middle">E</forename><surname>Fields</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Richard</forename><forename type="middle">A</forename><surname>Flavell</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.immuni.2006.03.007</idno>
		<idno type="PMID">16618596</idno>
	</analytic>
	<monogr>
		<title level="j">Immunity</title>
		<title level="j" type="abbrev">Immunity</title>
		<idno type="ISSN">1074-7613</idno>
		<imprint>
			<biblScope unit="volume">24</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="369" to="379" />
			<date type="published" when="2006-04" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">Control of Effector CD8+ T Cell Function by the Transcription Factor Eomesodermin</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">E</forename><forename type="middle">L</forename><surname>Pearce</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><forename type="middle">C</forename><surname>Mullen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><forename type="middle">A</forename><surname>Martins</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><forename type="middle">M</forename><surname>Krawczyk</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><forename type="middle">S</forename><surname>Hutchins</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">V</forename><forename type="middle">P</forename><surname>Zediak</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Banica</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><forename type="middle">B</forename><surname>Dicioccio</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><forename type="middle">A</forename><surname>Gross</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><forename type="middle">A</forename><surname>Mao</surname></persName>
		</author>
		<idno type="DOI">10.1126/science.1090148</idno>
		<idno type="PMID">14605368</idno>
	</analytic>
	<monogr>
		<title level="j">Science</title>
		<title level="j" type="abbrev">Science</title>
		<idno type="ISSN">0036-8075</idno>
		<idno type="ISSNe">1095-9203</idno>
		<imprint>
			<biblScope unit="volume">302</biblScope>
			<biblScope unit="issue">5647</biblScope>
			<biblScope unit="page" from="1041" to="1043" />
			<date type="published" when="2003-11-07" />
			<publisher>American Association for the Advancement of Science (AAAS)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">Effector and memory CD8+ T cell fate coupled by T-bet and eomesodermin</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Andrew</forename><forename type="middle">M</forename><surname>Intlekofer</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Naofumi</forename><surname>Takemoto</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">E</forename><forename type="middle">John</forename><surname>Wherry</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Sarah</forename><forename type="middle">A</forename><surname>Longworth</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">John</forename><forename type="middle">T</forename><surname>Northrup</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Vikram</forename><forename type="middle">R</forename><surname>Palanivel</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Alan</forename><forename type="middle">C</forename><surname>Mullen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Christopher</forename><forename type="middle">R</forename><surname>Gasink</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Susan</forename><forename type="middle">M</forename><surname>Kaech</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Joseph</forename><forename type="middle">D</forename><surname>Miller</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Laurent</forename><surname>Gapin</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Kenneth</forename><surname>Ryan</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Andreas</forename><forename type="middle">P</forename><surname>Russ</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Tullia</forename><surname>Lindsten</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jordan</forename><forename type="middle">S</forename><surname>Orange</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ananda</forename><forename type="middle">W</forename><surname>Goldrath</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Rafi</forename><surname>Ahmed</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Steven</forename><forename type="middle">L</forename><surname>Reiner</surname></persName>
		</author>
		<idno type="DOI">10.1038/ni1268</idno>
		<idno type="PMID">16273099</idno>
		<idno type="ark">ark:/67375/GT4-HSN4JN5S-F</idno>
		<idno type="istexId">D0759F1241BD663B74F56EA4A4612CA4507C0BD7</idno>
	</analytic>
	<monogr>
		<title level="j">Nature Immunology</title>
		<title level="j" type="abbrev">Nat Immunol</title>
		<idno type="ISSN">1529-2908</idno>
		<idno type="ISSNe">1529-2916</idno>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="issue">12</biblScope>
			<biblScope unit="page" from="1236" to="1244" />
			<date type="published" when="2005-11-06" />
			<publisher>Springer Nature</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">Anomalous Type 17 Response to Viral Infection by CD8+ T Cells Lacking T-bet and Eomesodermin</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><forename type="middle">M</forename><surname>Intlekofer</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Banerjee</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">N</forename><surname>Takemoto</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><forename type="middle">M</forename><surname>Gordon</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><forename type="middle">S</forename><surname>Dejong</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><surname>Shin</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><forename type="middle">A</forename><surname>Hunter</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">E</forename><forename type="middle">J</forename><surname>Wherry</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><surname>Lindsten</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><forename type="middle">L</forename><surname>Reiner</surname></persName>
		</author>
		<idno type="DOI">10.1126/science.1159806</idno>
		<idno type="PMID">18635804</idno>
		<idno type="PMCID">PMC2807624</idno>
		<ptr type="open-access" target="http://europepmc.org/articles/pmc2807624?pdf=render" />
	</analytic>
	<monogr>
		<title level="j">Science</title>
		<title level="j" type="abbrev">Science</title>
		<idno type="ISSN">0036-8075</idno>
		<idno type="ISSNe">1095-9203</idno>
		<imprint>
			<biblScope unit="volume">321</biblScope>
			<biblScope unit="issue">5887</biblScope>
			<biblScope unit="page" from="408" to="411" />
			<date type="published" when="2008-07-18" />
			<publisher>American Association for the Advancement of Science (AAAS)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">The role of the Runx transcription factors in thymocyte differentiation and in homeostasis of naive T cells</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Takeshi</forename><surname>Egawa</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Robert</forename><forename type="middle">E</forename><surname>Tillman</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yoshinori</forename><surname>Naoe</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ichiro</forename><surname>Taniuchi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Dan</forename><forename type="middle">R</forename><surname>Littman</surname></persName>
		</author>
		<idno type="DOI">10.1084/jem.20070133</idno>
		<idno type="PMID">17646406</idno>
		<idno type="PMCID">PMC2118679</idno>
		<ptr type="open-access" target="http://jem.rupress.org/content/204/8/1945.full.pdf" />
	</analytic>
	<monogr>
		<title level="j">The Journal of Experimental Medicine</title>
		<title level="j" type="abbrev">J Exp Med</title>
		<idno type="ISSN">0022-1007</idno>
		<idno type="ISSNe">1540-9538</idno>
		<imprint>
			<biblScope unit="volume">204</biblScope>
			<biblScope unit="issue">8</biblScope>
			<biblScope unit="page" from="1945" to="1957" />
			<date type="published" when="2007-07-23" />
			<publisher>Rockefeller University Press</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">Repression of the Transcription Factor Th-POK by Runx Complexes in Cytotoxic T Cell Development</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><surname>Setoguchi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Tachibana</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Y</forename><surname>Naoe</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Muroi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><surname>Akiyama</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><surname>Tezuka</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><surname>Okuda</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">I</forename><surname>Taniuchi</surname></persName>
		</author>
		<idno type="DOI">10.1126/science.1151844</idno>
		<idno type="PMID">18258917</idno>
	</analytic>
	<monogr>
		<title level="j">Science</title>
		<title level="j" type="abbrev">Science</title>
		<idno type="ISSN">0036-8075</idno>
		<idno type="ISSNe">1095-9203</idno>
		<imprint>
			<biblScope unit="volume">319</biblScope>
			<biblScope unit="issue">5864</biblScope>
			<biblScope unit="page" from="822" to="825" />
			<date type="published" when="2008-02-08" />
			<publisher>American Association for the Advancement of Science (AAAS)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">Differential Requirements for Runx Proteins in CD4 Repression and Epigenetic Silencing during T Lymphocyte Development</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ichiro</forename><surname>Taniuchi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Motomi</forename><surname>Osato</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Takeshi</forename><surname>Egawa</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Mary</forename><forename type="middle">Jean</forename><surname>Sunshine</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Suk-Chul</forename><surname>Bae</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Toshihisa</forename><surname>Komori</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yoshiaki</forename><surname>Ito</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Dan</forename><forename type="middle">R</forename><surname>Littman</surname></persName>
		</author>
		<idno type="DOI">10.1016/s0092-8674(02)01111-x</idno>
		<idno type="PMID">12464175</idno>
	</analytic>
	<monogr>
		<title level="j">Cell</title>
		<title level="j" type="abbrev">Cell</title>
		<idno type="ISSN">0092-8674</idno>
		<imprint>
			<biblScope unit="volume">111</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="621" to="633" />
			<date type="published" when="2002-11" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">Runx3 and Runx1 are required for CD8 T cell development during thymopoiesis</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">E</forename><surname>Woolf</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><surname>Xiao</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">O</forename><surname>Fainaru</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Lotem</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><surname>Rosen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">V</forename><surname>Negreanu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Y</forename><surname>Bernstein</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><surname>Goldenberg</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">O</forename><surname>Brenner</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><surname>Berke</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><surname>Levanon</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Y</forename><surname>Groner</surname></persName>
		</author>
		<idno type="DOI">10.1073/pnas.1232420100</idno>
		<idno type="PMID">12796513</idno>
		<idno type="PMCID">PMC164656</idno>
		<ptr type="open-access" target="http://www.pnas.org/content/100/13/7731.full.pdf" />
	</analytic>
	<monogr>
		<title level="j">Proceedings of the National Academy of Sciences</title>
		<title level="j" type="abbrev">Proceedings of the National Academy of Sciences</title>
		<idno type="ISSN">0027-8424</idno>
		<idno type="ISSNe">1091-6490</idno>
		<imprint>
			<biblScope unit="volume">100</biblScope>
			<biblScope unit="issue">13</biblScope>
			<biblScope unit="page" from="7731" to="7736" />
			<date type="published" when="2003-06-09" />
			<publisher>Proceedings of the National Academy of Sciences</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<monogr>
		<title/>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><surname>Brief</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><surname>Report</surname></persName>
		</author>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">Analyzing Expression of Perforin, Runx3, and Thpok Genes during Positive Selection Reveals Activation of CD8-Differentiation Programs by MHC II-Signaled Thymocytes</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">X</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">B</forename><forename type="middle">J</forename><surname>Taylor</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><surname>Sun</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><surname>Bosselut</surname></persName>
		</author>
		<idno type="DOI">10.4049/jimmunol.175.7.4465</idno>
		<idno type="PMID">16177089</idno>
		<ptr type="open-access" target="http://www.jimmunol.org/content/175/7/4465.full.pdf" />
	</analytic>
	<monogr>
		<title level="j">The Journal of Immunology</title>
		<title level="j" type="abbrev">The Journal of Immunology</title>
		<idno type="ISSN">0022-1767</idno>
		<idno type="ISSNe">1550-6606</idno>
		<imprint>
			<biblScope unit="volume">175</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page" from="4465" to="4474" />
			<date type="published" when="2005-09-21" />
			<publisher>The American Association of Immunologists</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">Transcription factors T-bet and Runx3 cooperate to activate Ifng and silence Il4 in T helper type 1 cells</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ivana</forename><forename type="middle">M</forename><surname>Djuretic</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ditsa</forename><surname>Levanon</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Varda</forename><surname>Negreanu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yoram</forename><surname>Groner</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Anjana</forename><surname>Rao</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><forename type="middle">Mark</forename><surname>Ansel</surname></persName>
		</author>
		<idno type="DOI">10.1038/ni1424</idno>
		<idno type="PMID">17195845</idno>
		<idno type="ark">ark:/67375/GT4-N6G2Z37H-T</idno>
		<idno type="istexId">26D94500E23F245AC2EE1C17B2C86FA1E67E4B8D</idno>
	</analytic>
	<monogr>
		<title level="j">Nature Immunology</title>
		<title level="j" type="abbrev">Nat Immunol</title>
		<idno type="ISSN">1529-2908</idno>
		<idno type="ISSNe">1529-2916</idno>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="145" to="153" />
			<date type="published" when="2006-12-31" />
			<publisher>Springer Nature</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">Repression of interleukin-4 in T helper type 1 cells by Runx/Cbfβ binding to theIl4silencer</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yoshinori</forename><surname>Naoe</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ruka</forename><surname>Setoguchi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Kaori</forename><surname>Akiyama</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Sawako</forename><surname>Muroi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Masahiko</forename><surname>Kuroda</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Farah</forename><surname>Hatam</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Dan</forename><forename type="middle">R</forename><surname>Littman</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ichiro</forename><surname>Taniuchi</surname></persName>
		</author>
		<idno type="DOI">10.1084/jem.20062456</idno>
		<idno type="PMID">17646405</idno>
		<idno type="PMCID">PMC2118685</idno>
		<ptr type="open-access" target="http://jem.rupress.org/content/204/8/1749.full.pdf" />
	</analytic>
	<monogr>
		<title level="j">The Journal of Experimental Medicine</title>
		<title level="j" type="abbrev">J Exp Med</title>
		<idno type="ISSN">0022-1007</idno>
		<idno type="ISSNe">1540-9538</idno>
		<imprint>
			<biblScope unit="volume">204</biblScope>
			<biblScope unit="issue">8</biblScope>
			<biblScope unit="page" from="1749" to="1755" />
			<date type="published" when="2007-07-23" />
			<publisher>Rockefeller University Press</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">Distinct Effects of T-bet in TH1 Lineage Commitment and IFN-gamma Production in CD4 and CD8 T Cells</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><forename type="middle">J</forename><surname>Szabo</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">B</forename><forename type="middle">M</forename><surname>Sullivan</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><surname>Stemmann</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><forename type="middle">R</forename><surname>Satoskar</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">B</forename><forename type="middle">P</forename><surname>Sleckman</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><forename type="middle">H</forename><surname>Glimcher</surname></persName>
		</author>
		<idno type="DOI">10.1126/science.1065543</idno>
		<idno type="PMID">11786644</idno>
	</analytic>
	<monogr>
		<title level="j">Science</title>
		<idno type="ISSN">0036-8075</idno>
		<idno type="ISSNe">1095-9203</idno>
		<imprint>
			<biblScope unit="volume">295</biblScope>
			<biblScope unit="issue">5553</biblScope>
			<biblScope unit="page" from="338" to="342" />
			<date type="published" when="2002-01-11" />
			<publisher>American Association for the Advancement of Science (AAAS)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">Perforin is activated by a proteolytic cleavage during biosynthesis which reveals a phospholipid-binding C2 domain</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><surname>Uellner</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">J</forename><surname>Zvelebil</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Hopkins</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Jones</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><forename type="middle">K</forename><surname>Macdougall</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">B</forename><forename type="middle">P</forename><surname>Morgan</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">E</forename><surname>Podack</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">D</forename><surname>Waterfi Eld</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><forename type="middle">M</forename></persName>
		</author>
		<idno type="DOI">10.1093/emboj/16.24.7287</idno>
		<idno type="PMID">9405358</idno>
		<idno type="PMCID">PMC1170329</idno>
		<idno type="ark">ark:/67375/WNG-030ZJ1XN-6</idno>
		<idno type="istexId">9010FD951518523B61BABC086BCCEBE06CD64497</idno>
		<ptr type="open-access" target="http://europepmc.org/articles/pmc1170329?pdf=render" />
	</analytic>
	<monogr>
		<title level="j">The EMBO Journal</title>
		<idno type="ISSNe">1460-2075</idno>
		<imprint>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="issue">24</biblScope>
			<biblScope unit="page" from="7287" to="7296" />
			<date type="published" when="1997-12-15" />
			<publisher>Wiley</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">Immediate Cytotoxicity But Not Degranulation Distinguishes Effector and Memory Subsets of CD8+T Cells</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Petra</forename><surname>Wolint</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Michael</forename><forename type="middle">R</forename><surname>Betts</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Richard</forename><forename type="middle">A</forename><surname>Koup</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Annette</forename><surname>Oxenius</surname></persName>
		</author>
		<idno type="DOI">10.1084/jem.20031799</idno>
		<idno type="PMID">15051762</idno>
		<idno type="PMCID">PMC2211884</idno>
		<ptr type="open-access" target="http://jem.rupress.org/content/jem/199/7/925.full.pdf" />
	</analytic>
	<monogr>
		<title level="j">The Journal of Experimental Medicine</title>
		<title level="j" type="abbrev">J Exp Med</title>
		<idno type="ISSN">0022-1007</idno>
		<idno type="ISSNe">1540-9538</idno>
		<imprint>
			<biblScope unit="volume">199</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page" from="925" to="936" />
			<date type="published" when="2004-03-29" />
			<publisher>Rockefeller University Press</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">Recent developments in the transcriptional regulation of cytolytic effector cells</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Laurie</forename><forename type="middle">H</forename><surname>Glimcher</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Michael</forename><forename type="middle">J</forename><surname>Townsend</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Brandon</forename><forename type="middle">M</forename><surname>Sullivan</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Graham</forename><forename type="middle">M</forename><surname>Lord</surname></persName>
		</author>
		<idno type="DOI">10.1038/nri1490</idno>
		<idno type="PMID">15516969</idno>
		<idno type="ark">ark:/67375/GT4-S0813D59-5</idno>
		<idno type="istexId">E3C65621C0CF9FEBCCE7BF68EF58EAC69F5FA082</idno>
	</analytic>
	<monogr>
		<title level="j">Nature Reviews Immunology</title>
		<title level="j" type="abbrev">Nat Rev Immunol</title>
		<idno type="ISSN">1474-1733</idno>
		<idno type="ISSNe">1474-1741</idno>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="issue">11</biblScope>
			<biblScope unit="page" from="900" to="911" />
			<date type="published" when="2004-11" />
			<publisher>Springer Nature</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">Antigen-driven effector CD8 T cell function regulated by T-bet</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">B</forename><forename type="middle">M</forename><surname>Sullivan</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Juedes</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><forename type="middle">J</forename><surname>Szabo</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Von Herrath</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><forename type="middle">H</forename><surname>Glimcher</surname></persName>
		</author>
		<idno type="DOI">10.1073/pnas.2636938100</idno>
		<idno type="PMID">14673093</idno>
		<idno type="PMCID">PMC307651</idno>
		<ptr type="open-access" target="http://www.pnas.org/content/100/26/15818.full.pdf" />
	</analytic>
	<monogr>
		<title level="j">Proceedings of the National Academy of Sciences</title>
		<title level="j" type="abbrev">Proceedings of the National Academy of Sciences</title>
		<idno type="ISSN">0027-8424</idno>
		<idno type="ISSNe">1091-6490</idno>
		<imprint>
			<biblScope unit="volume">100</biblScope>
			<biblScope unit="issue">26</biblScope>
			<biblScope unit="page" from="15818" to="15823" />
			<date type="published" when="2003-12-12" />
			<publisher>Proceedings of the National Academy of Sciences</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">Shaping a helper T cell identity</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Harinder</forename><surname>Singh</surname></persName>
		</author>
		<idno type="DOI">10.1038/ni0207-119</idno>
		<idno type="PMID">17242680</idno>
		<idno type="ark">ark:/67375/GT4-1116LL71-2</idno>
		<idno type="istexId">EB763B6FF221630CF3FEE9F53AAEB08039DB8B7F</idno>
	</analytic>
	<monogr>
		<title level="j">Nature Immunology</title>
		<title level="j" type="abbrev">Nat Immunol</title>
		<idno type="ISSN">1529-2908</idno>
		<idno type="ISSNe">1529-2916</idno>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="119" to="120" />
			<date type="published" when="2007-02" />
			<publisher>Springer Nature</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">Interleukin 2 Receptor Signaling Regulates the Perforin Gene through Signal Transducer and Activator of Transcription (Stat)5 Activation of Two Enhancers</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jin</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Irinoulla</forename><surname>Scordi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Mark</forename><forename type="middle">J</forename><surname>Smyth</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Mathias</forename><forename type="middle">G</forename><surname>Lichtenheld</surname></persName>
		</author>
		<idno type="DOI">10.1084/jem.190.9.1297</idno>
		<idno type="PMID">10544201</idno>
		<idno type="PMCID">PMC2195674</idno>
		<ptr type="open-access" target="http://jem.rupress.org/content/190/9/1297.full.pdf" />
	</analytic>
	<monogr>
		<title level="j">The Journal of Experimental Medicine</title>
		<title level="j" type="abbrev">J Exp Med</title>
		<idno type="ISSN">0022-1007</idno>
		<idno type="ISSNe">1540-9538</idno>
		<imprint>
			<biblScope unit="volume">190</biblScope>
			<biblScope unit="issue">9</biblScope>
			<biblScope unit="page" from="1297" to="1308" />
			<date type="published" when="1999-11-01" />
			<publisher>Rockefeller University Press</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">Chromosome Transfer Activates and Delineates a Locus Control Region for Perforin</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Matthew</forename><forename type="middle">E</forename><surname>Pipkin</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Belma</forename><surname>Ljutic</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Fernando</forename><surname>Cruz-Guilloty</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Marcela</forename><surname>Nouzova</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Anjana</forename><surname>Rao</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Juan</forename><forename type="middle">Carlos</forename><surname>Zúñiga-Pflücker</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Mathias</forename><forename type="middle">G</forename><surname>Lichtenheld</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.immuni.2006.11.009</idno>
		<idno type="PMID">17222571</idno>
	</analytic>
	<monogr>
		<title level="j">Immunity</title>
		<title level="j" type="abbrev">Immunity</title>
		<idno type="ISSN">1074-7613</idno>
		<imprint>
			<biblScope unit="volume">26</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="29" to="41" />
			<date type="published" when="2007-01" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">Regulation of Interferon‐γ During Innate and Adaptive Immune Responses</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jamie</forename><forename type="middle">R</forename><surname>Schoenborn</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Christopher</forename><forename type="middle">B</forename><surname>Wilson</surname></persName>
		</author>
		<idno type="DOI">10.1016/s0065-2776(07)96002-2</idno>
		<idno type="PMID">17981204</idno>
	</analytic>
	<monogr>
		<title level="m">Advances in Immunology</title>
		<imprint>
			<publisher>Elsevier</publisher>
			<date type="published" when="2007" />
			<biblScope unit="volume">96</biblScope>
			<biblScope unit="page" from="41" to="101" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">T-bet Regulates the Terminal Maturation and Homeostasis of NK and Vα14i NKT Cells</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Michael</forename><forename type="middle">J</forename><surname>Townsend</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Amy</forename><forename type="middle">S</forename><surname>Weinmann</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jennifer</forename><forename type="middle">L</forename><surname>Matsuda</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Rachelle</forename><surname>Salomon</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Peggy</forename><forename type="middle">J</forename><surname>Farnham</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Christine</forename><forename type="middle">A</forename><surname>Biron</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Laurent</forename><surname>Gapin</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Laurie</forename><forename type="middle">H</forename><surname>Glimcher</surname></persName>
		</author>
		<idno type="DOI">10.1016/s1074-7613(04)00076-7</idno>
		<idno type="PMID">15084276</idno>
	</analytic>
	<monogr>
		<title level="j">Immunity</title>
		<title level="j" type="abbrev">Immunity</title>
		<idno type="ISSN">1074-7613</idno>
		<imprint>
			<biblScope unit="volume">20</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="477" to="494" />
			<date type="published" when="2004-04" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">Eomesodermin is required for mouse trophoblast development and mesoderm formation</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Andreas</forename><forename type="middle">P</forename><surname>Russ</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Sigrid</forename><surname>Wattler</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">William</forename><forename type="middle">H</forename><surname>Colledge</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Samuel</forename><forename type="middle">A J R</forename><surname>Aparicio</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Mark</forename><forename type="middle">B L</forename><surname>Carlton</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jonathan</forename><forename type="middle">J</forename><surname>Pearce</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Sheila</forename><forename type="middle">C</forename><surname>Barton</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">Azim</forename><surname>Surani</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Kenneth</forename><surname>Ryan</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Michael</forename><forename type="middle">C</forename><surname>Nehls</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Valerie</forename><surname>Wilson</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Martin</forename><forename type="middle">J</forename><surname>Evans</surname></persName>
		</author>
		<idno type="DOI">10.1038/35003601</idno>
		<idno type="PMID">10716450</idno>
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<title level="j" type="abbrev">Nature</title>
		<idno type="ISSN">0028-0836</idno>
		<idno type="ISSNe">1476-4687</idno>
		<imprint>
			<biblScope unit="volume">404</biblScope>
			<biblScope unit="issue">6773</biblScope>
			<biblScope unit="page" from="95" to="99" />
			<date type="published" when="2000-03" />
			<publisher>Springer Nature</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main">Deletion of a conserved Il4 silencer impairs T helper type 1–mediated immunity</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><forename type="middle">Mark</forename><surname>Ansel</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Rebecca</forename><forename type="middle">J</forename><surname>Greenwald</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Suneet</forename><surname>Agarwal</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Craig</forename><forename type="middle">H</forename><surname>Bassing</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Silvia</forename><surname>Monticelli</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jeneen</forename><surname>Interlandi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ivana</forename><forename type="middle">M</forename><surname>Djuretic</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Dong</forename><forename type="middle">U</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Arlene</forename><forename type="middle">H</forename><surname>Sharpe</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Frederick</forename><forename type="middle">W</forename><surname>Alt</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Anjana</forename><surname>Rao</surname></persName>
		</author>
		<idno type="DOI">10.1038/ni1135</idno>
		<idno type="PMID">15516924</idno>
		<idno type="ark">ark:/67375/GT4-G8C3JT6W-J</idno>
		<idno type="istexId">4EE072A723791F263F02FC33E6A24C6DB9AED9BD</idno>
	</analytic>
	<monogr>
		<title level="j">Nature Immunology</title>
		<title level="j" type="abbrev">Nat Immunol</title>
		<idno type="ISSN">1529-2908</idno>
		<idno type="ISSNe">1529-2916</idno>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<biblScope unit="issue">12</biblScope>
			<biblScope unit="page" from="1251" to="1259" />
			<date type="published" when="2004-10-31" />
			<publisher>Springer Nature</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main">A reliable method to display authentic DNase I hypersensitive sites at long-ranges in single-copy genes from large genomes</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">E</forename><surname>Pipkin</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">G</forename><surname>Lichtenheld</surname></persName>
		</author>
		<idno type="DOI">10.1093/nar/gkl006</idno>
		<idno type="PMID">16510851</idno>
		<idno type="PMCID">PMC1388096</idno>
		<idno type="ark">ark:/67375/HXZ-CR3S43JG-8</idno>
		<idno type="istexId">5EF0673364DEEBCCD71F63409A5B7A8329B4AE7F</idno>
		<ptr type="open-access" target="https://academic.oup.com/nar/article-pdf/34/4/e34/4158217/gkl006.pdf" />
	</analytic>
	<monogr>
		<title level="j">Nucleic Acids Research</title>
		<title level="j" type="abbrev">Nucleic Acids Research</title>
		<idno type="ISSN">0305-1048</idno>
		<idno type="ISSNe">1362-4962</idno>
		<imprint>
			<biblScope unit="volume">34</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="e34" to="e34" />
			<date type="published" when="2006-02-13" />
			<publisher>Oxford University Press (OUP)</publisher>
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
